Status:

RECRUITING

Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility

Lead Sponsor:

University of Ottawa

Collaborating Sponsors:

Children's Hospital of Eastern Ontario

Alberta Children's Hospital

Conditions:

Cancer

Parent

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Clinical levels of fear of cancer recurrence (FCR) affect up to 59% of adult cancer survivors. Family caregivers experience equal or greater levels of FCR, which has been linked to lower quality of li...

Detailed Description

Pilot Study: 36 parents will be recruited to participate in the study. Additionally, 3 therapists with extensive online support group experience to conduct the Parent-FORT videoconference therapy ses...

Eligibility Criteria

Inclusion Criteria:

  • Parent (or primary caregiver) caring for a childhood cancer survivor (<18 years of age) of any type of cancer type, who is at least 1 months from the completion of active treatment and has not had a recurrence of their cancer
  • A score of 13 or greater on the Fear of Cancer Recurrence Inventory-Short Form-Parent version (FCRI-SF-P; range 0-36), suggesting clinical levels of FCR
  • Access to a computer and internet connection
  • Living in Canada

Exclusion Criteria:

  • Being the parent of a pediatric cancer survivor who is now 18 years of age or older
  • Being the parent of a pediatric cancer survivor who has undergone hematopoietic cell transplantation and has active chronic or acute graft-versus-host disease which has not stabilized for at least 3 months
  • Non-English speakers
  • Currently participating in another therapist-led psychosocial therapy group
  • Parent with unmanaged/undermanaged mental health disorder judged to be clinically contraindicated and/or likely to affect the group work
  • To avoid violating the assumption of nonindependence of the data, only one parent/caregiver per child can participate in the study.

Key Trial Info

Start Date :

August 26 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 26 2027

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT06872840

Start Date

August 26 2025

End Date

May 26 2027

Last Update

September 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Ottawa

Ottawa, Ontario, Canada, K1N6N5

Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility | DecenTrialz